Diamond Biotechnology Co., Ltd
Diamond Biotechnology Co., Ltd researches, develops, manufactures, and sells medical equipment and skincare products in Taiwan and internationally. The company offers skin care products under the Timera and Diamond Beauty brands. It also leases medical equipment. Diamond Biotechnology Co., Ltd was founded in 2014 and is based in Taipei, Taiwan.
Diamond Biotechnology Co., Ltd (6815) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.034x
Based on the latest financial reports, Diamond Biotechnology Co., Ltd (6815) has a cash flow conversion efficiency ratio of -0.034x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-21.17 Million) by net assets (NT$617.26 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Diamond Biotechnology Co., Ltd - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Diamond Biotechnology Co., Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Diamond Biotechnology Co., Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Diamond Biotechnology Co., Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jalles Machado S/A
SA:JALL3
|
0.096x |
|
Mayfield Group Holdings Ltd
AU:MYG
|
0.339x |
|
Wielton S.A.
WAR:WLT
|
-0.070x |
|
Treasury Metals Inc
F:TRC1
|
-0.041x |
|
365330
KQ:365330
|
-0.070x |
|
Dicot Pharma AB
F:KN0
|
-0.275x |
|
Frontier Energy Ltd
AU:FHE
|
-0.012x |
|
CATES ELEKTRIK
IS:CATES
|
-0.034x |
Annual Cash Flow Conversion Efficiency for Diamond Biotechnology Co., Ltd (2019–2024)
The table below shows the annual cash flow conversion efficiency of Diamond Biotechnology Co., Ltd from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$623.05 Million | NT$33.70 Million | 0.054x | -54.20% |
| 2023-12-31 | NT$346.39 Million | NT$40.90 Million | 0.118x | -77.31% |
| 2022-12-31 | NT$302.69 Million | NT$157.53 Million | 0.520x | +2417.92% |
| 2021-12-31 | NT$273.11 Million | NT$5.64 Million | 0.021x | -93.26% |
| 2020-12-31 | NT$232.19 Million | NT$71.17 Million | 0.306x | +519.99% |
| 2019-12-31 | NT$468.38 Million | NT$23.16 Million | 0.049x | -- |